Evidence map›Paper›PMID 24763136›Full record

ReviewHuman vaccines & immunotherapeutics2014

Pneumococcal conjugate vaccines for adults: reasons for optimism and for caution.

Daniel M Weinberger, Eugene D Shapiro

Abstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Rationale and prospects for novel pneumococcal vaccines.Human vaccines & immunotherapeutics · 2016
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel M WeinbergerDepartment of Epidemiology of Microbial Diseases; Yale School of Public Health; New Haven, CT USA.
Eugene D ShapiroDepartment of Epidemiology of Microbial Diseases; Yale School of Public Health; New Haven, CT USA; Department of Pediatrics; Yale University School of Medicine and Department of Investigative Medicine; Yale Graduate School of Arts and Sciences; New Haven, CT USA.

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Yale University Clinical and Translational Science Award ProgramKL2TR000140 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$2.9M
NCATS NIH HHS KL2 TR000140NCATS NIH HHS UL1 TR000142
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAnimalsHumansPneumococcal VaccinesPneumonia, PneumococcalRandomized Controlled Trials as TopicVaccines, Conjugate13-valent pneumococcal vaccinePneumococcal VaccinesVaccines, Conjugateconjugate vaccinespneumococcuspneumoniapreventionvaccines

Identifiers

PMID24763136
PMCPMC4896592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.